Tumor necrosis factor alpha expression is increased in maternal microvascular endothelial cells in preeclampsia

References

• Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308(5728):1592–1594.
   PubMed Web of Science ®Google Scholar
• Steegers EA, Von Dadelszen P, Duvekot JJ, et al. Pre-eclampsia. Lancet. 2010;376(9741):631–644. Epub 2010/ 07/06.
   PubMed Web of Science ®Google Scholar
• Benyo DF, Smarason A, Redman CW, et al. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab. 2001;86(6):2505–2512. Epub 2001/ 06/09.
   PubMed Web of Science ®Google Scholar
• Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 2003;10:45–65. Epub 2003/ 03/26.
   PubMed Web of Science ®Google Scholar
• Urschel K, Cicha I. TNF-alpha in the cardiovascular system: from physiology to therapy. Int J Interferon Cytokine Mediator Res. 2015;7:9–25.
   Google Scholar
• Williams TJ, Hellewell PG. Endothelial cell biology. Adhesion molecules involved in the microvascular inflammatory response. Am Rev Respir Dis. 1992;146(5_pt_2):S45–50. Epub 1992/ 11/01.
   PubMedGoogle Scholar
• Pober JS. Activation and injury of endothelial cells by cytokines. Pathol Biol. 1998;46(3):159–163. Epub 1998/ 10/14.
   PubMedGoogle Scholar
• Tran LT, MacLeod KM, McNeill JH. Chronic etanercept treatment prevents the development of hypertension in fructose-fed rats. Mol Cell Biochem. 2009;330(1–2):219–228. Epub 2009/ 05/15.
   PubMed Web of Science ®Google Scholar
• Zhang W, Li XJ, Zeng X, et al. Activation of nuclear factor-kappaB pathway is responsible for tumor necrosis factor-alpha-induced up-regulation of endothelin B2 receptor expression in vascular smooth muscle cells in vitro. Toxicol Lett. 2012;209(2):107–112. Epub 2011/ 12/31.
   PubMed Web of Science ®Google Scholar
• LaMarca B, Speed J, Fournier L, et al. Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade. Hypertension. 2008;52(6):1161–1167. Epub 2008/11/05.
   PubMed Web of Science ®Google Scholar
• Sunderland N, Hennessy A, Makris A. Animal models of pre-eclampsia. AmJReprodImmunol. 2011;65:533–541.
   Google Scholar
• Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, et al. Tumor necrosis factor-alpha and pregnancy: focus on biologics. An updated and comprehensive review. Clin Rev Allergy Immunol. 2017;53(1):40–53. Epub 2017/ 01/06.
   PubMed Web of Science ®Google Scholar
• Lee DK, Nevo O. Microvascular endothelial cells from preeclamptic women exhibit altered expression of angiogenic and vasopressor factors. Am J Physiol Heart Circ Physiol. 2016;310(11):H1834–41. Epub 2016/ 05/21.
   PubMed Web of Science ®Google Scholar
• Hypertension in pregnancy. Report of the American college of obstetricians and gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol. 2013;122(5):1122–1131. Epub 2013/ 10/24.
   PubMed Web of Science ®Google Scholar
• Hewett PW. Vascular endothelial cells from human micro- and macrovessels: isolation, characterisation and culture. Methods MolBiol. 2009;467:95–111.
   PubMedGoogle Scholar
• Nevo O, Soleymanlou N, Wu Y, et al. Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. AmJPhysiol RegulIntegrComp Physiol. 2006;291:R1085–R93.
   PubMed Web of Science ®Google Scholar
• Soleymanlou N, Jurisica I, Nevo O, et al. Molecular evidence of placental hypoxia in preeclampsia. JClinEndocrinolMetab. 2005;90:4299–4308.
   PubMed Web of Science ®Google Scholar
• Cheng YF, Young GH, Lin JT, et al. Activation of AMP-activated protein kinase by adenine alleviates TNF-alpha-induced inflammation in human umbilical vein endothelial cells. PLoS One. 2015;10(11):e0142283. Epub 2015/ 11/07.
   PubMed Web of Science ®Google Scholar
• De Ceunynck K, Peters CG, Jain A, et al. PAR1 agonists stimulate APC-like endothelial cytoprotection and confer resistance to thromboinflammatory injury. Proc Natl Acad Sci U S A. 2018;115(5):E982–E91. Epub 2018/ 01/19.
   PubMed Web of Science ®Google Scholar
• Surapisitchat J, Hoefen RJ, Pi X, et al. Fluid shear stress inhibits TNF-alpha activation of JNK but not ERK1/2 or p38 in human umbilical vein endothelial cells: inhibitory crosstalk among MAPK family members. Proc Natl Acad Sci U S A. 2001;98(11):6476–6481. Epub 2001/ 05/17.
   PubMed Web of Science ®Google Scholar
• Haider S, Knofler M. Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium. Placenta. 2009;30(2):111–123. Epub 2008/ 11/26.
   PubMed Web of Science ®Google Scholar
• Saito S, Nakashima A, Shima T. Ito M. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol. 2010;63(6):601–610. Epub 2010/ 05/12.
   PubMed Web of Science ®Google Scholar
• Bakrania BA, Spradley FT, Satchell SC, et al. Heme oxygenase-1 is a potent inhibitor of placental ischemia-mediated endothelin-1 production in cultured human glomerular endothelial cells. Am J Physiol Regul Integr Comp Physiol. 2018;314(3):R427–R32. Epub 2017/ 12/08.
   PubMed Web of Science ®Google Scholar
• Virdis A, Duranti E, Rossi C, et al. Tumour necrosis factor-alpha participates on the endothelin-1/nitric oxide imbalance in small arteries from obese patients: role of perivascular adipose tissue. Eur Heart J. 2015;36(13):784–794. Epub 2014/ 03/01.
   PubMed Web of Science ®Google Scholar
• He Y, Xiao Y, Yang X, et al. SIRT6 inhibits TNF-alpha-induced inflammation of vascular adventitial fibroblasts through ROS and Akt signaling pathway. Exp Cell Res. 2017;357(1):88–97. Epub 2017/ 05/10.
   PubMed Web of Science ®Google Scholar
• Hunkapiller NM, Gasperowicz M, Kapidzic M, et al. A role for Notch signaling in trophoblast endovascular invasion and in the pathogenesis of pre-eclampsia. Development. 2011;138(14):2987–2998. Epub 2011/ 06/23.
   PubMed Web of Science ®Google Scholar
• Meekins JW, McLaughlin PJ, West DC, et al. Endothelial cell activation by tumour necrosis factor-alpha (TNF-alpha) and the development of pre-eclampsia. Clin Exp Immunol. 1994;98(1):110–114. Epub 1994/ 10/01.
   PubMed Web of Science ®Google Scholar
• Shaw J, Tang Z, Schneider H, et al. Inflammatory processes are specifically enhanced in endothelial cells by placental-derived TNF-alpha: implications in preeclampsia (PE). Placenta. 2016;43:1–8. Epub 2016/ 06/22.
   PubMed Web of Science ®Google Scholar
• Bechard D, Meignin V, Scherpereel A, et al. Characterization of the secreted form of endothelial-cell-specific molecule 1 by specific monoclonal antibodies. J Vasc Res. 2000;37(5):417–425. Epub 2000/ 10/12.
   PubMed Web of Science ®Google Scholar
• Adekola H, Romero R, Chaemsaithong P, et al. Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes. J Matern Fetal Neonatal Med. 2015;28(14):1621–1632. Epub 2014/ 09/12.
   PubMed Web of Science ®Google Scholar
• Cakmak M, Yilmaz H, Baglar E, et al. Serum levels of endocan correlate with the presence and severity of pre-eclampsia. Clin Exp Hypertens. 2016;38(2):137–142. Epub 2015/ 09/30.
   PubMed Web of Science ®Google Scholar
• Hentschke MR, Lucas LS, Mistry HD. Pinheiro da Costa BE, Poli-de-Figueiredo CE. Endocan-1 concentrations in maternal and fetal plasma and placentae in pre-eclampsia in the third trimester of pregnancy. Cytokine. 2015;74(1):152–156. Epub 2015/ 05/11.
   PubMed Web of Science ®Google Scholar
• Imai T, Hirata Y, Emori T, et al. Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells. Hypertension. 1992;19(6_pt_2):753–757. Epub 1992/ 06/01.
   PubMed Web of Science ®Google Scholar
• Hobson SR, Acharya R, Lim R, et al. Role of activin A in the pathogenesis of endothelial cell dysfunction in preeclampsia. Pregnancy Hypertens. 2016;6(2):130–133. Epub 2016/ 05/09.
   PubMed Web of Science ®Google Scholar
• Martinez-Miguel P, Medrano-Andres D, Griera-Merino M, et al. Tweak up-regulates endothelin-1 system in mouse and human endothelial cells. Cardiovasc Res. 2017;113(2):207–221. Epub 2016/ 12/28.
   PubMed Web of Science ®Google Scholar
• Chen MM, Ashley EA, Deng DX, et al. Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation. 2003;108(12):1432–1439. Epub 2003/ 09/10.
   PubMed Web of Science ®Google Scholar
• De Mota N, Reaux-Le Goazigo A, El Messari S, et al. Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release. Proc Natl Acad Sci U S A. 2004;101(28):10464–10469. Epub 2004/ 07/03.
   PubMed Web of Science ®Google Scholar
• Ishida J, Hashimoto T, Hashimoto Y, et al. Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo. J Biol Chem. 2004;279(25):26274–26279. Epub 2004/ 04/17.
   PubMed Web of Science ®Google Scholar
• Lee DK, George SR, O’Dowd BF. Unravelling the roles of the apelin system: prospective therapeutic applications in heart failure and obesity. Trends Pharmacol Sci. 2006;27(4):190–194. Epub 2006/ 03/15.
   PubMed Web of Science ®Google Scholar
• Salcedo A, Garijo J, Monge L, et al. Apelin effects in human splanchnic arteries. Role of nitric oxide and prostanoids. Regul Pept. 2007;144(1–3):50–55. Epub 2007/ 07/14.
   PubMed Web of Science ®Google Scholar